| Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown F Cinque, A Cespiati, R Lombardi, A Costantino, G Maffi, F Alletto, ... Nutrients 14 (3), 556, 2022 | 15 | 2022 |
| Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both E Crisafulli, G Sartori, A Vianello, F Busti, A Nobili, PM Mannucci, D Girelli Internal and Emergency Medicine 18 (2), 523-534, 2023 | 8 | 2023 |
| Nutritional and Lifestyle Therapy for NAFLD in People with HIV F Cinque, A Cespiati, R Lombardi, G Guaraldi, G Sebastiani Nutrients 15 (8), 1990, 2023 | 7 | 2023 |
| An Overview of hepatocellular carcinoma surveillance focusing on non-cirrhotic NAFLD patients: A challenge for physicians A Cespiati, F Cinque, M Meroni, R Lombardi, P Dongiovanni, ... Biomedicines 11 (2), 586, 2023 | 6 | 2023 |
| The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV G Guaraldi, J Milic, S Renzetti, F Motta, F Cinque, J Bischoff, A Desilani, ... AIDS, 10.1097, 2022 | 5 | 2022 |
| People living with HIV and NAFLD—A population left behind in the global effort for liver fibrosis screening? G Sebastiani, J Milic, EA Tsochatzis, C Marzolini, M Betel, S Bhagani, ... Hepatology 78 (5), E87-E88, 2023 | 4 | 2023 |
| Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology P Raggi, J Milic, M Manicardi, F Cinque, MG Swain, G Sebastiani, ... Atherosclerosis, 117523, 2024 | 3 | 2024 |
| Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism A Filtz, A Carandina, A Fasiello, L Barbetta, R Lombardi, F Cinque, ... Internal and Emergency Medicine 18 (2), 359-366, 2023 | 3 | 2023 |
| MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality? R Lombardi, A Cespiati, P Francione, F Cinque, S Fargion, AL Fracanzani METABOLISM AND TARGET ORGAN DAMAGE 1 (2), 1-12, 2021 | 3 | 2021 |
| Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades R Lombardi, L Colavolpe, F Alletto, A Cespiati, E Fatta, C Bertelli, ... Digestive and Liver Disease 56 (1), 144-151, 2024 | 2 | 2024 |
| Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort F Cinque, S Saeed, D Kablawi, LR Ballesteros, W Elgretli, EEM Moodie, ... BMJ open 13 (8), e076547, 2023 | 2 | 2023 |
| Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis? G Sebastiani, F Cinque, A Cascio, JK Rockstroh, G Guaraldi Journal of Hepatology 82 (1), e18-e20, 2025 | 1 | 2025 |
| What not to overlook in the management of patients with type 2 diabetes mellitus: the nephrological and hepatological perspectives CM Alfieri, P Molinari, F Cinque, S Vettoretti, A Cespiati, D Bignamini, ... International journal of molecular sciences 25 (14), 7728, 2024 | 1 | 2024 |
| Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients S Cicco, M D′ Abbondanza, M Proietti, V Zaccone, C Pes, F Caradio, ... European Journal of Clinical Investigation 53 (4), e13931, 2023 | 1 | 2023 |
| SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study R Lombardi, A Cespiati, A Mantovani, G Maffi, E Del Zanna, P Francione, ... Digestive and Liver Disease 55, S42, 2023 | 1 | 2023 |
| The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis R Riccardo, F Cinque, K Patel, G Sebastiani Expert Review of Gastroenterology & Hepatology, 2025 | | 2025 |
| Metabolic dysfunction‐associated steatohepatitis exhibits sex differences in people with HIV D Kablawi, J Milic, T Thomas, T Fotsing Tadjo, F Cinque, W Elgretli, ... HIV medicine 25 (11), 1259-1269, 2024 | | 2024 |
| Material deprivation is associated with liver stiffness and liver‐related outcomes in people with HIV C Long, F Cinque, D Kablawi, DHD Kim, TF Tadjo, W Elgretli, ... Liver International 44 (10), 2615-2624, 2024 | | 2024 |
| Navigating the Maze: A Mini-Guide for the Management and Therapy of Metabolic Dysfunction-associated Steatotic Liver Disease G Sebastiani, F Cinque Canadian Primary Care Today, 34–40-34–40, 2024 | | 2024 |
| Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease R Righetti, F Cinque, MT Volpe, G Sebastiani Expert Review of Gastroenterology & Hepatology 18 (7), 303-313, 2024 | | 2024 |
